
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript May 12, 2025 Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.16, expectations were $0.08. Operator: Greetings, and welcome to the Aurinia …